26 studies found for:    " May 02, 2012":" June 01, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" May 02, 2012":" June 01, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression
Condition: Human Immunodeficiency Virus
Intervention: Drug: Atazanavir, ritonavir, lamivudine
2 Unknown  A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV
Condition: HIV Dementia
Interventions: Drug: Long acting methylphenidate;   Drug: Matched placebo
3 Recruiting Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)
Condition: HIV Dementia
Interventions: Drug: Atorvastatin (generic Lipitor);   Drug: placebo
4 Completed A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1265744 Oral;   Drug: GSK1265744 LAP 800mg intramuscular injection;   Drug: GSK1265744 LAP 200mg subcutaneous injection;   Drug: GSK1265744 LAP 200mg intramuscular injection;   Drug: GSK1265744 LAP 400mg intramuscular injection;   Drug: TMC278 LA 1200mg intramuscular injection;   Drug: TMC278 LA 600mg intramuscular injection
5 Completed A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: Maraviroc;   Drug: Combivir;   Drug: GSK2838510
6 Recruiting Alcohol's Impact on Inflammatory Markers in HIV Disease - Russia ARCH Cohort
Conditions: HIV Infection;   Alcohol Use
Intervention:
7 Unknown  Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women
Conditions: HIV Infection;   Pregnancy
Intervention:
8 Active, not recruiting Linking Infectious and Narcology Care in Russia
Conditions: HIV Infection;   Drug Use
Intervention: Behavioral: LINC Case Management
9 Enrolling by invitation HIV Disclosure and Medication Adherence, a Pilot Study
Condition: HIV Infection
Intervention:
10 Completed Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy
Condition: HIV-infection
Intervention: Drug: Darunavir/ritonavir
11 Completed Evaluation of the Bioequivalence of a Combined Formulated Tablet
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg;   Drug: Dolutegravir 50 mg;   Drug: abacavir 600 mg/lamivudine 300 mg
12 Active, not recruiting A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women
Conditions: Cancer Prevention;   Cervix
Interventions: Behavioral: Cognitive Interview;   Behavioral: Questionnaires;   Behavioral: Focus Groups
13 Recruiting Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV
Conditions: HIV Infection;   Tuberculosis
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Raltegravir;   Drug: Isoniazid;   Drug: Pyridoxine;   Drug: Pyrazinamide;   Drug: Ethambutol;   Drug: Rifabutin;   Drug: Rifampin
14 Active, not recruiting Effects of a Protein Calorie Supplement in HIV-infected Women With Tuberculosis
Conditions: HIV;   Tuberculosis
Interventions: Dietary Supplement: Protein calorie supplement;   Dietary Supplement: Micronutrient
15 Completed Outcomes for Antiretroviral Therapy Patients Receiving Palliative Care
Condition: HIV
Interventions: Other: Palliative care;   Other: Standard care
16 Withdrawn Pharmacokinetics, Pharmacodynamics and Cervicovaginal Lavage of Combined Oral Contraceptives and Raltegravir
Condition: HIV
Intervention:
17 Recruiting Gene Expression in HIV and Tuberculosis Co-infection
Conditions: Tuberculosis;   HIV;   IRIS
Intervention:
18 Recruiting Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIV
Condition: HIV/AIDS
Interventions: Behavioral: BCAP peer-driven intervention (PDI);   Behavioral: Control intervention
19 Recruiting Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients
Condition: HIV-2 Infection
Intervention: Drug: emtricitabine / tenofovir disoproxil fumarate / raltegravir .
20 Completed Enhancing HIV Risk Reduction Among Indian Women With Risky Husbands
Condition: Behavioral Risk for HIV
Intervention: Behavioral: RHANI WIves

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Indicates status has not been verified in more than two years